AMRI licenses Teewinot's cannabinoid analytical standard production tech

By Gareth Macdonald contact

- Last updated on GMT

iStock/Thom_Morris
iStock/Thom_Morris

Related tags: Research, Technology

AMRI has licensed technology needed to make an analytical standard drug firms working with cannabinoids can use for research and quality control.

The technology used to make the CBCA analytical standard was developed by Teewinot Life Sciences.

Teewinot CEO Jeffrey Korentur told us “researchers will be able to use the standard validate and confirm that the compound they are using either is, or is not, CBCA. Standards may have other uses in research and development including preliminary efficacy studies​.”

He added that: “AMRI is licensed to use our technology to manufacture and sell the CBCA analytical standard​.”

Teewinot has a suite of biosynthetic technologies it uses to make cannabinoid-based compounds in micro-organisms.

The idea is that the approach is faster and more consistent than plant-based production.

Scale-up

The agreement with AMRI is seperate to the deal Teewinot has with the US contractor to scale up the cannabinoid production process.

Korentur told us: “Our scale up is in progress now, and we anticipate being able to produce kilogram quantities of GMP manufactured cannabinoids by Q1 2017​.”

Tech license

News of the deal comes a week after Florida-based Teewinot licensed rights to its cannabinoid active pharmaceutical ingredient (API) manufacturing technology to Nemus Biosciences.

That agreement was signed days after Teewinot’s Ireland-based subsidiary, Full Spectrum Laboratories, was granted a US patent​ for the technology. 

Related news

Show more

Related products

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers